Gonda, Kenji
Yaginuma, Kenji
Rokkaku, Yuichi
Horita, Shoichiro
Maejima, Yuko
Shimomura, Kenju
Article History
Received: 18 August 2019
Accepted: 16 October 2019
First Online: 28 October 2019
Ethics approval and consent to participate
: The institutional review board and the local ethics committee (the Ethics Review Board of Japan Community Healthcare Organization Nihonmatsu Hospital, no. 00037) approved the study. All procedures were performed in accordance with the ethical standards of the responsible committee on human experimentation at Fukushima Medical University and with the Helsinki Declaration of 1975, as revised in 2000. Each author certifies that all investigations were conducted in conformity with the ethical principles.The average MMSE score of the 13 subjects with solid cancers and cognitive impairment was 22.6, and that for the 14 subjects with cognitive impairment alone was 21.4. Based on the ≤ 23 MMSE score of the patients in this study, it may be said that the patients were in cognitive decline. We reviewed the consent form that was submitted to the ethics review board, in reference to the background and design of the LASA (The Longitudinal Aging Study Amsterdam) study. We obtained the qualifications for specialist in intractable disease designation from the governor of Fukushima. An example of an intractable disease designated by the Japanese Ministry of Health, Labour and Welfare is frontal head dementia or dementia in young people. Written informed consent to participate in the study was obtained from the legal guardians or representatives of the 13 subjects with solid cancers and cognitive impairment and the 14 subjects with cognitive impairment alone.
: Not applicable.
: The authors declare that they have no competing interests.